Clinical Interests: Dr. Chabra has a keen interest in helping decrease bronchopulmonary dysplasia in the extremely low birth weight preterm neonates, especially with regards to the role of non‐invasive ventilation and preterm nutrition including vitamin A. She is passionate about the management of infants with gastroschisis, both prenatal and postnatal. She helped develop the Seattle Children’s gastroschisis clinical pathway that is evidence-based and is being used statewide and continues to update and review these guidelines.

Scholarly Focus: Outcomes of gastroschisis, especially with regards to the effects of prematurity and small‐for‐gestational age including the optimal ultrasound formulae to assess fetal growth restriction and utility of a checklist to determine the timing of delivery. Other interests include preterm nutrition and post-natal growth, optimal Vitamin D dose in infants, long‐term effects of pregnancy infections on child health; bronchopulmonary dysplasia and role of non‐invasive ventilation; evaluation of safety of commonly used drugs in lactating women and breastfed infants; outcomes of late and moderately preterm infants and trends in gastroschisis outcomes.

Research funding:

2018‐2023 PK and safety of commonly used drugs in lactating women and breastfed infants. NIH/NICHD/Subcontract Duke University. NIH contract number HHSN‐27520100003I. Role: Co‐Investigator, PI: Mary Hebert, PharmD, FCCP. Annual Direct costs: $79,000

Purpose: To evaluate the pharmacokinetics and safety of commonly used drugs in infant exposure during lactation.

Administration/Education Roles: As a member of the AAP Advocacy committee and the Washington Chapter Vaccine subcommittee, she has advocated for childhood vaccinations and helped disseminate the AAP Hepatitis B vaccine guidelines. She is extremely passionate about resident and fellow ‘trainee wellbeing’ leading a national workshop on “Promoting physician wellness” and has been the Neonatology Fellows Professional support and wellness supervisor. She has been involved in several quality improvement projects such as effects of effects of 39‐week initiative on late preterm births, impact of empiric antibiotic treatment for maternal chorioamnionitis on exclusive breastfeeding, Optimal Vitamin D dosing and timely administration of birth dose of hepatitis B vaccine. She serves on Hospital Peer-Review committees and is an active member of the CHNC gastroschisis focus group. She has served as physician advisor for Washington State Hospital Association and helped establish the Overlake infant nutrition clinic, adopted as the Washington State Department of Health model for preterm infants’ safe transition from hospital to home. She loves educating Pediatric residents/fellows and has also mentored master’s students at University of Washington and several Pediatric Residents and Neonatology Fellows who are the future of Neonatology.